3 terminated. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Terminated 3 |
| Phase 2 | 2 | Terminated 2 |
Follow Hematoma: new trials by email Literature Review of Hematoma trials Research Report on Hematoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tocilizumab (RoActemra) and Tranexamic Acid (Cyklokapron) Used as Adjuncts to Chronic Subdural Hematoma Surgery Tranexamic acid and Tocilizumab - Chronic Subdural Hematoma | Phase 2 / Phase 3 | Terminated | Oslo University Hospital | 382 | 2017-11-28 | 2021-10-13 |
| Dexamethasone Versus Burr Hole Craniostomy for Symptomatic Chronic Subdural Hematoma Dexamethasone, Burr Hole Craniostomy - Chronic Subdural Hematoma | Phase 2 / Phase 3 | Terminated | University of Virginia | 10 | 2014-03-01 | 2018-12-11 |
| Interest of Oral Corticosteroids in the Treatment of Chronic Subdural Hematomas oral corticosteroids, placebo - Chronic Intracranial Subdural Hematoma | Phase 3 | Terminated | University Hospital, Montpellier | 162 | 2011-07-22 | 2026-06-02 |
Hematoma, Subdural, Chronic (3) · Recurrence (1)
Brain Diseases (3) · Cardiovascular Diseases (3) · Central Nervous System Diseases (3) · Cerebrovascular Disorders (3) · Chronic Disease (3) · Craniocerebral Trauma (3) · Disease Attributes (3) · Hematoma, Subdural (3) · Hemorrhage (3) · Intracranial Hemorrhage, Traumatic (3) · Intracranial Hemorrhages (3) · Nervous System Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3)
Adrenal Cortex Hormones (1) · Dexamethasone (1) · Prednisone (1) · Tranexamic Acid (1) · tocilizumab (1)
Oslo University Hospital (1) · University Hospital, Montpellier (1) · University of Virginia (1)
France (1) · Norway (1) · United States (1)
Jennifer De Jong (1) · Lonjon Nicolas, MD,PhD (1) · Milo Stanisic (1)
2009 (1), 2017 (1)